Celularity (CELUW) Inventory Average (2021 - 2025)
Celularity (CELUW) reported Inventory Average of $1.6 million for Q4 2025, down 66.56% year-over-year from $4.7 million in Q4 2024, and down 55.06% quarter-over-quarter from $3.5 million in Q3 2025.
Celularity (CELUW) Inventory Average (2021 - 2025) Analysis & Trends
Celularity (CELUW) has 5 years of Inventory Average data on file, last reported at $1.6 million in Q4 2025.
- Inventory Average for Q4 2025 came in at $1.6 million, down 66.56% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.6 million (down 66.56% YoY), and the FY2025 annual result was $3.0 million, down 46.43% from the prior year.
- Inventory Average retreated to $1.6 million in Q4 2025 per CELUW's latest filing, from $3.5 million in the prior quarter.
- Over five years, Inventory Average peaked at $19.7 million in Q2 2022 and troughed at $1.6 million in Q4 2025.
- A 5-year average of $6.7 million and a median of $5.3 million in 2023 frame the typical range for Inventory Average.
- The sharpest annual moves came in 2023 and 2025: Inventory Average tumbled 71.5% in 2023, then surged 60.32% in 2025.
- A 5-year view of Inventory Average shows it stood at $7.6 million in 2021, then slumped by 31.05% to $5.3 million in 2022, then climbed by 1.33% to $5.3 million in 2023, then retreated by 12.3% to $4.7 million in 2024, then tumbled by 66.56% to $1.6 million in 2025.
- Business Quant data shows CELUW's Inventory Average at $1.6 million in Q4 2025, $3.5 million in Q3 2025, and $5.3 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 30.59 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.73 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Celularity | - | - | -3.27 Mn | 1.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.57 Mn |
| Sep 30, 2025 | 3.49 Mn |
| Jun 30, 2025 | 5.30 Mn |
| Mar 31, 2025 | 5.80 Mn |
| Dec 31, 2024 | 4.69 Mn |
| Sep 30, 2024 | 3.44 Mn |
| Jun 30, 2024 | 3.31 Mn |
| Mar 31, 2024 | 4.73 Mn |
| Dec 31, 2023 | 5.34 Mn |
| Sep 30, 2023 | 5.34 Mn |
| Jun 30, 2023 | 5.61 Mn |
| Mar 31, 2023 | 5.40 Mn |
| Dec 31, 2022 | 5.27 Mn |
| Sep 30, 2022 | 14.95 Mn |
| Jun 30, 2022 | 19.69 Mn |
| Mar 31, 2022 | 12.13 Mn |
| Dec 31, 2021 | 7.65 Mn |